Mahmut Gozelle

Hit evaluation results in 5-benzyl-1,3,4-thiadiazole-2-carboxamide based SIRT2-selective inhibitor with improved affinity and selectivity.

G. Eren, Y. Ozkan, M. Gozelle, 2022, Bioorganic chemistry.

The potential of 4-aryl-6-morpholino-3(2H)-pyridazinone-2-arylpiperazinylacetamide as a new scaffold for SIRT2 inhibition: in silico approach guided by pharmacophore mapping and molecular docking

G. Eren, Y. Ozkan, M. Gozelle, 2021, Medicinal Chemistry Research.

Hit-to-lead optimization on aryloxybenzamide derivative virtual screening hit against SIRT.

G. Eren, Y. Ozkan, Selen Gozde Kaya, 2020, Bioorganic & medicinal chemistry.

Pharmacophore modeling and virtual screening studies to identify novel selective SIRT2 inhibitors.

R. Cetin-Atalay, G. Costantino, G. Eren, 2019, Journal of molecular graphics & modelling.

Enzalutamide-human serum albumin interaction: Electrochemical exploration of complex formation and binding parameters

N. Bakirhan, M. Doulache, E. B. Atici, 2024, Microchemical Journal.

In silico approach reveals N-(5-phenoxythiophen-2-yl)-2-(arylthio)acetamides as promising selective SIRT2 inhibitors: the case of structural optimization of virtual screening-derived hits.

A. Massarotti, G. Eren, Y. Ozkan, 2023, Journal of biomolecular structure & dynamics.